Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $10.4900 (8.76%) ($10.1000 - $10.5980) on Mon. Nov. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4% (three month average) | RSI | 43 | Latest Price | $10.4900(8.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.8% a day on average for past five trading days. | Weekly Trend | AUTL declines -3.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) ARKG(12%) BLOK(12%) BNDX(12%) SKYY(12%) XBI(12%) | Factors Impacting AUTL price | AUTL will decline at least -2% in a week (0% probabilities). TBT(-8%) USO(-7%) VIXM(-6%) UNG(-6%) XLF(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2% (StdDev 4%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $0.85(-91.9%) | Resistance Level | $10.84 | 5 Day Moving Average | $10.2(2.84%) | 10 Day Moving Average | $10.55(-0.57%) | 20 Day Moving Average | $10.84(-3.23%) | To recent high | -28.5% | To recent low | 8.8% | Market Cap | $548m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |